Cabaletta Bio, Inc. (CABA) Stock Forecast & Price Prediction 2024, 2025, 2030, 2040, and 2050
Find Cabaletta Bio, Inc. (CABA) short-term stock forecasts for 2024 by month and long-term price predictions for 2024 to 2050. View past performance, analyst Buy, Sell or Hold ratings, and the latest CABA stock news and headlines.
1 Month Prediction
$25.30 [981.18%]
3 Month Prediction
$20.34 [769.02%]
6 Month Prediction
$11.15 [376.32%]
1 Year Prediction
$22.90 [878.49%]
3 Year Prediction
$13.39 [472.40%]
5 Year Prediction
$6.07 [159.19%]
About Cabaletta Bio, Inc.
Cabaletta Bio, Inc. is a clinical-stage biotechnology company that develops engineered T cell therapies for B cell-mediated autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania and was founded in the year 2017.
The company's proprietary Cabaletta Approach to B cell Ablation (CABA®) platform follows two strategies:
Chimeric Antigen Receptor T cells for Autoimmunity (CARTA): This approach includes the lead product candidate, CABA-201, an investigational 4-1BB-containing CD19-CAR T cell therapy based on a clinically evaluated fully human CD19 binder. CABA-201 is under development for systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and other autoimmune diseases with high unmet need.
Chimeric AutoAntibody Receptor T (CAART): This approach includes clinical-stage candidates such as DSG3-CAART for mucosal pemphigus vulgaris and MuSK-CAART for MuSK myasthenia gravis.
Cabaletta Bio has collaborations with institutions like the University of Pennsylvania and the Children's Hospital of Philadelphia to take its research and development efforts further.
As of December 2024, the company employs approximately 154 individuals.
Cabaletta Bio, Inc. (CABA) Historical Performance
IPO Date
Cabaletta Bio, Inc. (NASDAQ:CABA) went public on 25 October, 2019.
Change
Since inception, CABA has decreased by 82.92%. In the last 5 years, CABA has fallen from $16.43 to $2.34, a massive -85.76% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $22.88 and a low of $0.65.
52 Week Range
$1.76
$26.35
The current price $2.34 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
CABA Stock Price History
Based on CABA stock's historical price data, this table shows how the stock has performed in the last 5 years. Since 2019, the CABA stock has fallen from $7.25 - $16.43 to $2.34 - $22.88, which is down -30.18%. Currently, the stock follows downward trend.
Here, we have calculated stock range of CABA, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $7.25 - $16.43 | $11.45 | -17.24 | 1 Year Change |
| 2021 | $3.79 - $13.67 | $10.41 | -24.76 | 2 Year Change |
| 2022 | $0.65 - $9.25 | $2.43 | -82.44 | 3 Year Change |
| 2023 | $8.27 - $22.7 | $13.22 | -4.45 | 4 Year Change |
| 2024 | $2.34 - $22.88 | $9.66 | -30.18 | 5 Year Change |
CABA Price Performance
6-Month Performance
CABA stock dropped by 67.04% in the last six months.
1-Year Performance
The stock has trended downwards by 88.57% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 22.52%.
5-Year Performance
In the last 5 years, the stock has gone down by 85.76%.
According to Cabaletta Bio, Inc.'s historical data, below graph gives us the exact picture of how the CABA stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 2 years and a decline in 2 years.
2020
10.67% ↓
2021
69.63% ↓
2022
144.06% ↑
2023
145.41% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Cabaletta Bio, Inc. (CABA) Financials & Stock Analysis
Market Capitalization
Cabaletta Bio, Inc. has a market capitalization of $114.37M, which places CABA in the micro-cap category.
Fundamental Analysis
EPS: $-0.62 (Q3), $-1.65 (1Y)
EPS increased 10.71% since last quarter, and decreased 8.84% since last year.
Net Income: $-30.63 M (Q3), $-67.67 M (1Y)
Net Income increased 10.97% since last quarter, and increased 27.75% since last year.
Free Cash Flow: $-20.58 M (Q3), $-54.24 M (1Y)
Free Cash Flow decreased N/A since last quarter, and increased N/A since last year.
Below, we have listed 12 key indicators for Fundamental analysis for CABA stock. These indicators help you understand Cabaletta Bio, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for CABA stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $2.95 |
| SMA50 | $3.45 |
| SMA200 | $7.97 |
| RSI | 19.53 |
| Beta | 2.42 |
SMA20 > Current Price
This signals CABA stock is in short-term bearish momentum.
SMA50 > Current Price
This signals CABA stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals CABA stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for CABA stock is Bearish. Out of all indicators, 2 indicates bullish signals, 6 signals bearish trends and 1 gives neutral trends. The CABA stock forecast was last updated on 24 December, 2024.
Cabaletta Bio, Inc. (CABA) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $22.90 by the end of 2025, and can reach around $17.09 to $12.88 in 2026. And, the long-term forecast suggests that the stock may further jump to $15.99 - $5.45 in 2028, and $1.16 - $1.17 by 2031. So, the CABA stock shows a strong upward trend in the next several years.
Short-term CABA Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-01 | $25.30 | 981.2% |
| 2025-02 | $26.76 | 1043.59% |
| 2025-03 | $20.34 | 769.23% |
| 2025-04 | $13.60 | 481.2% |
| 2025-05 | $13.17 | 462.82% |
| 2025-06 | $11.15 | 376.5% |
| 2025-07 | $13.87 | 492.74% |
| 2025-08 | $13.40 | 472.65% |
| 2025-09 | $13.72 | 486.32% |
| 2025-10 | $12.82 | 447.86% |
| 2025-11 | $15.24 | 551.28% |
| 2025-12 | $22.90 | 878.63% |
In 2025, the CABA stock price is expected to fluctuate between $11.15 and $26.76. According to the monthly forecast, the stock could rise to $22.90 by December 2024. If compared to the CABA's current price, the stock could gain 878.63% by the end of this year.
Long-term CABA Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $17.09 | $8.37 | $12.88 | 450.43% |
| 2027 | $10.74 | $11.27 | $19.51 | 733.76% |
| 2028 | $15.99 | $4.04 | $5.45 | 132.91% |
| 2029 | $3.57 | $0.79 | $6.83 | 191.88% |
| 2030 | $5.04 | $1.40 | $0.92 | -60.68% |
| 2031 | $1.16 | $0.85 | $1.17 | -50.0% |
| 2032 | $1.07 | $1.18 | $0.86 | -63.25% |
| 2033 | $0.87 | $1.20 | $1.09 | -53.42% |
| 2034 | $1.20 | $1.41 | $0.92 | -60.68% |
| 2035 | $1.31 | $1.08 | $1.17 | -50.0% |
| 2036 | $0.93 | $0.78 | $0.77 | -67.09% |
| 2037 | $0.95 | $0.91 | $1.40 | -40.17% |
| 2038 | $0.66 | $1.36 | $0.99 | -57.69% |
| 2039 | $1.23 | $0.87 | $1.39 | -40.6% |
| 2040 | $0.99 | $1.21 | $0.94 | -59.83% |
| 2041 | $1.03 | $1.19 | $1.47 | -37.18% |
| 2042 | $0.82 | $1.05 | $1.12 | -52.14% |
| 2043 | $1.29 | $1.14 | $1.23 | -47.44% |
| 2044 | $1.23 | $0.96 | $0.78 | -66.67% |
| 2045 | $1.26 | $0.75 | $1.06 | -54.7% |
| 2046 | $1.05 | $0.86 | $1.12 | -52.14% |
| 2047 | $0.51 | $0.91 | $0.51 | -78.21% |
| 2048 | $1.05 | $0.78 | $0.79 | -66.24% |
| 2049 | $0.97 | $1.33 | $1.11 | -52.56% |
| 2050 | $1.08 | $1.13 | $0.79 | -66.24% |
Cabaletta Bio, Inc. (CABA) Stock Price Prediction & Forecast 2024 - 2025
At the start of 2024, the CABA stock was at $20.48. Today, it is trading at $2.34, which is -88.57% decrease from price at the beginning of the year.
In early 2025, the CABA price is expected to descend to $28.92, a change of 1135.80% from the current price. By mid-2025, the stock may move down by -23.82% on $22.03 and end the year at $16.19, which is 591.83% compared to today's price.
Cabaletta Bio, Inc. (CABA) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the CABA stock. During this period, the CABA's price is forecasted to shift from $17.09 to $0.92, which is -94.62% loss.
In 2026, the stock would possibly open at $17.09, descends to $8.37 by mid-year, and wraps up at $12.88, reflecting a 450.63% increase from today's price. Further moving to 2030, the stock can kick off the year at $5.04, drop to $1.40 by mid-year, and finish at $0.92, which is -60.56% change from current price.
Cabaletta Bio, Inc. (CABA) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $1.16 to $0.94, which is down -50.19%
In 2031, we can expect CABA to fluctuate between $1.16 and $1.17, a shift indicating a -50.19% loss by year-end compared to current price. And Until 2040, CABA can likely vary from $0.94 to $0.99. By the end of 2040, the stock could record a -59.62% fall from today's stock price.
Cabaletta Bio, Inc. (CABA) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the CABA stock can see an a downturn from $1.03 to $0.79 in this period. In 2041, the stock can experience a high of $1.19 by mid-year, closing the year at $1.47. This results in a -49.15% decrease from today.
Moving towards the end of 2050, CABA is projected to open the year at $1.08. The stock may peak to $1.13 during mid-year and finish the year at $0.79. Compared to the stock's current price, this translates to an overall loss of -66.09% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
CABA : Buy, Sell Or Hold?
Analyst Ratings
Based on 10 analysts, 1 rated as a strong buy, 7 recommended a buy, 2 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 10 analysts, 2 analysts gave a strong buy rating, 8 a buy rating, 0 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for CABA stock is Buy.
Expert Analysis
According to CABA short-term and long-term forecast, Cabaletta Bio, Inc. shares are projected to go down by 66.24%, and reach a value of $0.79 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, CABA has recorded 8/30 green days, which reflects a 38.095238095238095% positivity rate with a price volatility of 0.11%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that CABA stock is undervalued. So, Based on CABA prediction and analysis, it may be the best time to sell CABA stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "CABA” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.